Correlation Between Defence Therapeutics and ChitogenX

Can any of the company-specific risk be diversified away by investing in both Defence Therapeutics and ChitogenX at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Defence Therapeutics and ChitogenX into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Defence Therapeutics and ChitogenX, you can compare the effects of market volatilities on Defence Therapeutics and ChitogenX and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Defence Therapeutics with a short position of ChitogenX. Check out your portfolio center. Please also check ongoing floating volatility patterns of Defence Therapeutics and ChitogenX.

Diversification Opportunities for Defence Therapeutics and ChitogenX

-0.78

Correlation Coefficient

Defence Therapeutics  ChitogenX

Pay attention - limited upside

The 3 months correlation between Defence and ChitogenX is -0.78. Overlapping area represents the amount of risk that can be diversified away by holding Defence Therapeutics and ChitogenX in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ChitogenX and Defence Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Defence Therapeutics are associated (or correlated) with ChitogenX. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ChitogenX has no effect on the direction of Defence Therapeutics i.e., Defence Therapeutics and ChitogenX go up and down completely randomly.

Pair Corralation between Defence Therapeutics and ChitogenX

Assuming the 90 days horizon Defence Therapeutics is expected to generate 0.87 times more return on investment than ChitogenX. However, Defence Therapeutics is 1.15 times less risky than ChitogenX. It trades about 0.21 of its potential returns per unit of risk. ChitogenX is currently generating about -0.05 per unit of risk. If you would invest  39.00  in Defence Therapeutics on December 30, 2024 and sell it today you would earn a total of  61.00  from holding Defence Therapeutics or generate 156.41% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	98.46%
Values	Daily Returns

Defence Therapeutics  vs.  ChitogenX

Defence Therapeutics

Risk-Adjusted Performance

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Defence Therapeutics are ranked lower than 16 (%) of all global equities and portfolios over the last 90 days. Despite nearly weak technical and fundamental indicators, Defence Therapeutics reported solid returns over the last few months and may actually be approaching a breakup point.

ChitogenX

Risk-Adjusted Performance

Very Weak

Over the last 90 days ChitogenX has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Pair Trading with Defence Therapeutics and ChitogenX

The main advantage of trading using opposite Defence Therapeutics and ChitogenX positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Defence Therapeutics position performs unexpectedly, ChitogenX can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ChitogenX will offset losses from the drop in ChitogenX's long position.

The idea behind Defence Therapeutics and ChitogenX pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.